ResearchJun 12, 20260 views

A supramolecular KLVFF/graphene oxide/cyclodextrin assembly for selective recognition of amyloid β 42 peptide.

New research out of Italy shows how a clever supramolecular assembly can pick amyloid beta 42 (Aβ42) out of a crowd. The team combined the peptide KLVFF, graphene oxide flakes, and a specialized cyclodextrin nanovesicle to build an electrochemical platform for selectively recognizing Aβ42. Why does this matter? Because Aβ42 is a key peptide linked to Alzheimer’s pathology, and spotting it early could change the game for research into diagnostics.

Int J Biol Macromol

by Nocito G, Scuderi V, Turnaturi R et al.

“A supramolecular KLVFF/graphene oxide/cyclodextrin assembly for selective recognition of amyloid β 42 peptide. Nocito G(1), Scuderi V(2), Turnaturi R(3), Sabatino G(3), Filice S(2), Crispi S(2), Trapani M(1), Scala A(4), Pappalardo G(3), Scalese S(5), Mazzaglia A(6). Author information: (1)National Research Council, Institute for the Study of Nanostructured Materials (CNR-ISMN) URT of Messina at the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm), University of Messina - Viale Ferdinando Stagno d'Alcontres, 31 98166, Messina, Italy. (2)National Research Council, Institute for Microelectronics and Microsystems (CNR-IMM) Catania - VIII strada, 5 (Zona Industriale), 95121, Catania, Italy. (3)National Research Council, Institute of Crystallography (CNR-IC) Catania - Via Paolo Gaifami, 18 95126, Catania, Italy. (4)Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm), University of Messina - Viale Ferdinando Stagno d'Alcontres, 31 98166, Messina, Italy. (5)National Research Council, Institute for Microelectronics and Microsystems (CNR-IMM) Catania - VIII strada, 5 (Zona Industriale), 95121, Catania, Italy. Electronic address: silvia.scalese@cnr.it. (6)National Research Council, Institute for the Study of Nanostructured Materials (CNR-ISMN) URT of Messina at the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm), University of Messina - Viale Ferdinando Stagno d'Alcontres, 31 98166, Messina, Italy. Electronic address: antonino.mazzaglia@cnr.it. Early diagnosis can greatly improve quality of life in patients affected by severe diseases such as Alzheimer's (AD). Therefore, the development of alternative platforms for the improvement of clinical diagnostic methods is gaining increasing interest. In this scenario, nanotechnology offers the opportunity to design and tailor materials and devices on purpose. Following this lead, graphene oxide (GO) flakes were decorated with amphiphilic cyclodextrin heptakis[6-deoxy-6-hexadecylthio-2-poly(ethyleneglycol)]-β-cyclodextrin (SC16OH) nanovesicles entangling the hydrophobic peptide conjugate ferrocenyl-(PEG)4-KLVFF (Lys-Leu-Val-Phe-Phe, Aβ (16-20)). This supramolecular assembly, whose structural features enable electrochemical platforms to recognize the Aβ42 peptide, was characterized using spectroscopic and analytical techniques including cyclic voltammetry (CV), Fourier transform Infrared spectroscopy (FT-IR), circular dichroism (CD) and scanning electron microscopy (SEM). The interaction between the proposed platform and various Aβ peptides, such as Aβ42, Aβ40 scrambled (Aβ40s) and Aβ42 scrambled (Aβ42s) isoforms, was evaluated by CV pointing out specific and concentration-dependent recognition toward Aβ42. Copyright © 2026. Published by Elsevier B.V. Conflict of interest statement: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Antonino Mazzaglia reports financial support was provided by NextGenerationEU PNRR project SAMOTHRACE. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.”

Here’s the setup: the researchers took graphene oxide, then functionalized it with cyclodextrin nanovesicles. Into this, they added a hydrophobic peptide conjugate—ferrocenyl-(PEG)4-KLVFF. That’s a mouthful, but all you need to know is this assembly creates a stable, surface-ready platform. They then tested its ability to recognize different amyloid beta isoforms using cyclic voltammetry, FT-IR, circular dichroism, and SEM.

Key takeaway: this supramolecular platform shows specific, concentration-dependent recognition for Aβ42, beating out scrambled versions of the peptide. That’s selectivity researchers care about.

Why should you pay attention?

•

Electrochemical detection means potential for portable, fast, and sensitive research tools.

•

The approach is modular—swap in different recognition elements for different targets.

•

This platform could help screen compounds or map aggregation in Alzheimer’s models.

If you’re working in peptide analytics or interested in next-gen diagnostic methods, this is a signal to watch. The full methodology and results are a solid reference point for anyone looking to build out peptide-sensing tech or explore supramolecular assemblies.

For more on amyloid research and innovative peptide platforms, check out the peptide research index. Want to compare platforms or source reagents? The vendor directory has you covered.

This kind of work keeps the peptide field sharp—expect more creative assemblies like this to pop up.

Back to News Read original on Int J Biol Macromol

A supramolecular KLVFF/graphene oxide/cyclodextrin assembly for selective recognition of amyloid β 42 peptide.

Related Reading

The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.

Structure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.

Combining an α(v)β(6)-Targeted (177)Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.